z-logo
open-access-imgOpen Access
Interleukin-6, Cortisol, and Depressive Symptoms in Ovarian Cancer Patients
Author(s) -
Susan K. Lutgendorf,
Aliza Weinrib,
Frank J. Penedo,
Daniel W. Russell,
Koen DeGeest,
Erin S. Costanzo,
Patrick J. Henderson,
Sandra E. Sephton,
Nicolas Rohleder,
Joseph A. Lucci,
Steve W. Cole,
Anil K. Sood,
David M. Lubaroff
Publication year - 2008
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2007.14.1978
Subject(s) - medicine , depression (economics) , evening , ovarian cancer , cancer , endocrinology , gastroenterology , oncology , interleukin 6 , cytokine , physics , astronomy , economics , macroeconomics
Inflammatory processes have been implicated in the pathogenesis of both depression and cancer. Links between depressive symptoms, interleukin-6 (IL-6), and cortisol dysregulation have been demonstrated in cancer patients, but vegetative versus affective components of depression have been minimally examined. The objective of the current study was to examine associations between IL-6, diurnal cortisol rhythms, and facets of depression in epithelial ovarian cancer patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom